Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella…

Overview of attention for article published in Antimicrobial Resistance & Infection Control, April 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 7 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 80 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 49 publications that cite this research output.

49

The most recent citing publications are shown below. View all 49 publications that cite this research output on Dimensions.

Discerning the dissemination mechanisms of antibiotic resistance genes through whole genome sequencing of extended-spectrum beta-lactamase (ESBL)-producing E. coli isolated from veterinary clinics and farms in South Korea

Article in The Science of The Total Environment (March 2024)

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP

Article in Antibiotics (March 2024)

Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study

Article in Microorganisms (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.